Breakthrough First-in-Class Covalent Werner Helicase Inhibitor Demonstrates Clinical Proof-of-Concept in Phase I Trial
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine